Niagen Bioscience, Inc. (NAGE): Gross Profit

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2016-01-02 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$83.19M
Year ended 2025-12-31
$82.92M
Trailing 12 months to 2026-06-30
+24.8%
3-year compound annual growth
+18.7%
5-year compound annual growth
+27.1%
10-year compound annual growth
2011-01-01: $2.94M2011-12-31: $2.47M2012-12-29: $2.28M2013-12-28: $3.13M2015-01-03: $5.33M2016-01-02: $7.53M2016-12-31: $10.39M2017-12-30: $10.48M2018-12-31: $16.05M2019-12-31: $25.77M2020-12-31: $35.27M2021-12-31: $41.49M2022-12-31: $42.80M2023-12-31: $50.78M2024-12-31: $61.59M2025-12-31: $83.19M$83.19M
2011-01-01 Gross Profit (USD) 2025-12-31
Period endedGross ProfitChange YoYSource filing
2025-12-31$83.19M+35.1%2026-03-04, From 2025-01-01
2024-12-31$61.59M+21.3%2026-03-04, From 2024-01-01
2023-12-31$50.78M+18.7%2025-03-04, From 2023-01-01
2022-12-31$42.80M+3.2%2024-03-06, From 2022-01-01
2021-12-31$41.49M+17.6%2023-03-08, From 2021-01-01
2020-12-31$35.27M+36.9%2022-03-14, From 2020-01-01
2019-12-31$25.77M+60.5%2021-03-12, From 2019-01-01
2018-12-31$16.05M+53.2%2020-03-10, From 2017-12-31
2017-12-30$10.48M+0.8%2019-03-07, From 2017-01-01
2016-12-31$10.39M+37.9%2018-03-15, From 2016-01-03
2016-01-02, Fiscal 2015$7.53Mn/c2018-03-15, From 2015-01-04
2015-01-03, Fiscal 2014$5.33M+70.0%2017-03-16, From 2013-12-29
2013-12-28$3.13M+37.7%2016-03-17, From 2012-12-30
2012-12-29$2.28M-7.9%2014-03-27, From 2012-01-01
2011-12-31$2.47M-16.1%2013-03-29, From 2011-01-02
2011-01-01, Fiscal 2010$2.94Mn/a2012-03-15, From 2010-01-03

Gross Profit at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedGross ProfitChange YoY
Niagen Bioscience, Inc. (NAGE)2025-12-31$83.19M+35.1%
Natural Alternatives International Inc (NAII)2025-06-30$9.29M+35.3%
Cronos Group Inc. (CRON)2025-12-31$62.76M+149.1%
Mannatech Inc (MTEX)2025-12-31$80.96M-11.5%
Marimed Inc. (MRMD)2025-12-31$57.88M-7.6%
Glass House Brands Inc. (GLAS)2025-12-31$76.96M-21.0%
Fitlife Brands, Inc. (FTLF)2025-12-31$31.45M+12.0%
Jushi Holdings Inc. (JUSH)2025-12-31$113.98M-3.7%
Leef Brands Inc. (LEEEF)2025-12-31$10.48M+36.5%

Compare NAGE, NAII, CRON, MTEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗